NATHAN PETULA: Open Payments
NPI 1245363365 · SHIPPENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,109 in 183 payments from 27 companies in 2025. Trend: 2023 $2,999 · 2024 $3,193 · 2025 $3,109
Food & beverage: $3,109
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 37 | $638 |
| AstraZeneca Pharmaceuticals LP | 20 | $365 |
| ABBVIE INC. | 18 | $314 |
| Lilly USA, LLC | 19 | $249 |
| PFIZER INC. | 10 | $164 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $159 |
| Amgen Inc. | 14 | $138 |
| Exact Sciences Corporation | 5 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $115 |
| CeQur Corporation | 1 | $93 |
Products named: Wegovy, AIRSUPRA, Ozempic, XIFAXAN, VRAYLAR, MOUNJARO, FASENRA, Kerendia.
Industry payments across PA — which companies pay providers there.
